Detalhe da pesquisa
1.
Engineering, Structure and Immunogenicity of the Human Metapneumovirus F Protein in the Postfusion Conformation.
PLoS Pathog
; 12(9): e1005859, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27611367
2.
ISG15 Is Upregulated in Respiratory Syncytial Virus Infection and Reduces Virus Growth through Protein ISGylation.
J Virol
; 90(7): 3428-38, 2016 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-26763998
3.
Influence of Respiratory Syncytial Virus F Glycoprotein Conformation on Induction of Protective Immune Responses.
J Virol
; 90(11): 5485-5498, 2016 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27009962
4.
Characterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion Glycoprotein.
PLoS Pathog
; 11(7): e1005035, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26161532
5.
Trivalency of a Nanobody Specific for the Human Respiratory Syncytial Virus Fusion Glycoprotein Drastically Enhances Virus Neutralization and Impacts Escape Mutant Selection.
Antimicrob Agents Chemother
; 60(11): 6498-6509, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27550346
6.
Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection.
Antimicrob Agents Chemother
; 60(1): 6-13, 2016 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26438495
7.
Conservation of G-Protein Epitopes in Respiratory Syncytial Virus (Group A) Despite Broad Genetic Diversity: Is Antibody Selection Involved in Virus Evolution?
J Virol
; 89(15): 7776-85, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25995258
8.
A monomeric uncleaved respiratory syncytial virus F antigen retains prefusion-specific neutralizing epitopes.
J Virol
; 88(20): 11802-10, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25078705
9.
Clinical response to pandemic H1N1 influenza virus from a fatal and mild case in ferrets.
Virol J
; 12: 48, 2015 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-25888921
10.
Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention.
Proc Natl Acad Sci U S A
; 109(8): 3089-94, 2012 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-22323598
11.
Exploring the antigenic relatedness of influenza virus haemagglutinins with strain-specific polyclonal antibodies.
J Gen Virol
; 95(Pt 10): 2140-2145, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25000959
12.
Characterization of an enhanced antigenic change in the pandemic 2009 H1N1 influenza virus haemagglutinin.
J Gen Virol
; 95(Pt 5): 1033-1042, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24531414
13.
Influence of respiratory syncytial virus strain differences on pathogenesis and immunity.
Curr Top Microbiol Immunol
; 372: 59-82, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24362684
14.
Social, economic, and health impact of the respiratory syncytial virus: a systematic search.
BMC Infect Dis
; 14: 544, 2014 Oct 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-25358423
15.
Entry of enveloped viruses into host cells: membrane fusion.
Subcell Biochem
; 68: 467-87, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23737062
16.
Exogenous, TAP-independent lysosomal presentation of a respiratory syncytial virus CTL epitope.
Immunol Cell Biol
; 90(10): 978-82, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22929180
17.
Characterization of neutralizing affinity-matured human respiratory syncytial virus F binding antibodies in the sub-picomolar affinity range.
J Mol Recognit
; 25(3): 136-46, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22407977
18.
Recombinant Sendai viruses expressing fusion proteins with two furin cleavage sites mimic the syncytial and receptor-independent infection properties of respiratory syncytial virus.
J Virol
; 85(6): 2771-80, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21228237
19.
Residues of the human metapneumovirus fusion (F) protein critical for its strain-related fusion phenotype: implications for the virus replication cycle.
J Virol
; 85(23): 12650-61, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21937649
20.
Neutralization of human respiratory syncytial virus infectivity by antibodies and low-molecular-weight compounds targeted against the fusion glycoprotein.
J Virol
; 84(16): 7970-82, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20534864